Followers | 32 |
Posts | 2740 |
Boards Moderated | 0 |
Alias Born | 01/17/2014 |
Thursday, April 06, 2017 1:00:48 PM
Session 21: Nanoparticle Inks
Liquid Silicon Ink for Printable Active Components
Thursday, June 22, 2017
11:00 AM - 11:20 AM
A newly developed “liquid silicon” precursor will be discussed. Cyclohexasilane (CHS; Si6H12) has been used to make silicon-based films (such as polysilicon, silicon nitride, silicon carbide and others), as well as silicon nanowires and quantum dots will be discussed. CHS offers a more versatile, lower-cost and safer pathway to a variety of silicon based products being considered for flexible and printable electronics.
Speaker's Biography
Douglas W. Freitag brings 35 years of expertise in developing, commercializing, and financing new technologies. He joined 3Dicon in 2012 serving in the role of Federal Business Development. In 2013 he become the VP Technology and Business Development. In 2015 he became the acting CEO of Coretec Industries. In 2016 he became the CEO of 3DIcon and its subsidiary Coretec Industries following the companies merger. He now serves as the VP of Technology for the renamed Coretec Group. Mr. Freitag previously had a successful career in various management and engineering roles while employed by Lockheed Martin, Honeywell, and Ford Motor Company. Mr. Freitag has a technical background with a B.S. and M.S. in Mechanical Engineering from Purdue University. He has published and presented over seventy papers in advanced technologies and their commercialization, issued several patents, organized and chaired numerous technical sessions at national meetings, and participated in various government panels.
SPEAKER
Doug Freitag
The Coretec Group
Recent CRTG News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 02:51:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 06:06:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:43:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:41:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:40:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:38:33 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/31/2023 08:36:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 12:24:21 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM